🇺🇸 Ticagrelor 90 in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Renal Failure — 3 reports (13.64%)
  2. Rhabdomyolysis — 3 reports (13.64%)
  3. Alanine Aminotransferase Increased — 2 reports (9.09%)
  4. Asthenia — 2 reports (9.09%)
  5. Blood Alkaline Phosphatase Abnormal — 2 reports (9.09%)
  6. Blood Creatine Increased — 2 reports (9.09%)
  7. Blood Creatine Phosphokinase Mb Abnormal — 2 reports (9.09%)
  8. Chromaturia — 2 reports (9.09%)
  9. Decreased Appetite — 2 reports (9.09%)
  10. Disturbance In Attention — 2 reports (9.09%)

Source database →

Ticagrelor 90 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ticagrelor 90 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ticagrelor 90 in United States?

Sheffield Teaching Hospitals NHS Foundation Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.